Neurological

A new study has detected cognitive deficits in recovered COVID-19 patients, finding the more severe the case, the greater the persistent cognitive problems, with hospitalized patients put on ventilators showing a decline equivalent to seven IQ points.

An extraordinary new study is reporting the first direct demonstration of a psilocybin dose inducing neural plasticity in a mammalian brain. The researchers hypothesize this mechanism playing a role in the drug’s antidepressant qualities.

A detailed investigation into brain tissue from those who died from COVID-19 has found no trace of the SARS-CoV-2 virus, but “profound molecular markers of inflammation” were seen offering clues to explain long COVID symptoms.

In a new study, occipital nerve stimulation has been found to reduce the frequency and severity of headaches in patients suffering chronic cluster headaches, and the results suggest low doses of electrical stimulation are as effective as high doses.

Scientists at the University of Tokyo have come up with novel approach to tackling brain plaques associated with Alzheimer's, clearing them through the use of injectable, oxygenated atoms that are activated by infrared light.

A robust new study has comprehensively demonstrated how SARS-CoV-2, the coronavirus that causes COVID-19, can infect the brain and central nervous system. The study validates a growing body of research attributing neurological issues to COVID-19.

Scientists studying the mechanisms behind cellular stress and its effects on aging have found success in reversing cognitive decline in mice using an experimental drug, which bodes well for further study of aging and its effects in human subjects.

Research has suggested that anxiety is an early indicator for Alzheimer's disease, which often follows mild cognitive decline (MCI). A new study has now found a link between anxiety and an increased rate of progression from MCI to Alzheimer's disease.

A UK team has demonstrated a novel technology for imaging the brains of infants and babies. The breakthrough is hoped to allow researchers new ways to investigate baby brain activity in natural environments without the need for expensive MRI machines.

New research has shown how immune cells produced in the gut play a protective role during MS flare-ups. For the first time scientists have shown how these immune cells travel up to the brain and potentially help shift a disease flare-up into remission.

An exploratory study has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small but the promising findings suggest potential for psychedelics to treat migraines.

A new study is presenting a robust hypothesis to explain how a parasitic infection can alter behavior. The research provides new insights into how neurophysiological changes influence behavior, and points to novel therapeutic research targets.